Abstract
Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.
Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.
Current Medicinal Chemistry
Title:Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention
Volume: 21 Issue: 22
Author(s): B. Wang, H. Zhou, Y. Luo, R. Tang and S. Zheng
Affiliation:
Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.
Abstract: Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.
Export Options
About this article
Cite this article as:
Wang B., Zhou H., Luo Y., Tang R. and Zheng S., Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention, Current Medicinal Chemistry 2014; 21 (22) . https://dx.doi.org/10.2174/0929867321666131213102724
DOI https://dx.doi.org/10.2174/0929867321666131213102724 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Electrohydrodynamic Preparation of Nanomedicines
Current Topics in Medicinal Chemistry Novel Experimental Design for Steady-state Processes: A Systematic Bayesian Approach for Enzymes, Drug Transport, Receptor Binding, Continuous Culture and Cell Transport Kinetics
Medicinal Chemistry A Review on Extraction, Synthesis and Anticancer Activity of Betulinic Acid
Current Bioactive Compounds Challenges and Strategies in Precision Medicine for Non-Small-Cell Lung Cancer
Current Pharmaceutical Design The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets The Use of SIFT-MS to Investigate Headspace Aldehydes as Markers of Lipid Peroxidation
Current Analytical Chemistry Bioactive Heterocyclic Compounds as Potential Therapeutics in the Treatment of Gliomas: A Review
Anti-Cancer Agents in Medicinal Chemistry Emerging Facts on Chronic Consumption of Aspartame as Food Additive
Current Nutrition & Food Science Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Hybrid Compounds Containing Carvacrol Scaffold: <i>In Vitro</i> Antibacterial and Cytotoxicity Evaluation
Recent Advances in Anti-Infective Drug Discovery Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Preclinical Evidence on the Anticancer Properties of Food Peptides
Protein & Peptide Letters The Autism Candidate Gene Neurobeachin Encodes a Scaffolding Protein Implicated in Membrane Trafficking and Signaling
Current Molecular Medicine Anti-Angiogenesis in Glioblastoma: The Clinical Consequences of Redundancy and Evasion?
Current Angiogenesis (Discontinued) Sphingosine Kinases Signalling in Carcinogenesis
Mini-Reviews in Medicinal Chemistry SDResU-Net: Separable and Dilated Residual U-Net for MRI Brain Tumor Segmentation
Current Medical Imaging Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research Novel Benzimidazole Derivatives: Cytotoxic and Apoptotic Properties on Lung Cancer Cell Line
Letters in Drug Design & Discovery Mitophagy in Carcinogenesis and Tumour Progression- A New Paradigm with Emerging Importance
Anti-Cancer Agents in Medicinal Chemistry